{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:38:43Z","timestamp":1794285523091,"version":"4.9.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41433-022-02022-5","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:31:44Z","timestamp":1648528304000},"page":"1047-1060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Complications and post-operative interventions in XEN45 gel stent implantation in the treatment of open angle glaucoma\u2014a systematic review and meta-analysis"],"prefix":"10.1038","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-7514","authenticated-orcid":false,"given":"Bjorn Kaijun","family":"Betzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-4932","authenticated-orcid":false,"given":"Sheng Yang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Ang","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien Cherng Hui","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8256-4894","authenticated-orcid":false,"given":"Bryan Chin Hou","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"2022_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262\u20137.","journal-title":"Br J Ophthalmol"},{"key":"2022_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2147\/OPTH.S135316","volume":"11","author":"LE Pillunat","year":"2017","unstructured":"Pillunat LE, Erb C, Junemann AG, Kimmich F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clin Ophthalmol. 2017;11:1583\u2013600.","journal-title":"Clin Ophthalmol"},{"key":"2022_CR3","first-page":"785","volume":"9","author":"HG Lemij","year":"2015","unstructured":"Lemij HG, Hoevenaars JG, van der Windt C, Baudouin C. Patient satisfaction with glaucoma therapy: reality or myth? Clin Ophthalmol. 2015;9:785\u201393.","journal-title":"Clin Ophthalmol"},{"key":"2022_CR4","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.ophtha.2011.01.047","volume":"118","author":"DC Musch","year":"2011","unstructured":"Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R, Group CS. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118:1766\u201373.","journal-title":"Ophthalmology."},{"key":"2022_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.ophtha.2011.03.028","volume":"118","author":"BA Francis","year":"2011","unstructured":"Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, et al. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118:1466\u201380.","journal-title":"Ophthalmology"},{"key":"2022_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb H, Ahmed II. Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol. 2012;23:96\u2013104.","journal-title":"Curr Opin Ophthalmol"},{"key":"2022_CR7","doi-asserted-by":"publisher","first-page":"e0183142","DOI":"10.1371\/journal.pone.0183142","volume":"12","author":"C Lavia","year":"2017","unstructured":"Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS ONE. 2017;12:e0183142.","journal-title":"PLoS ONE"},{"key":"2022_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/08820538.2019.1581820","volume":"34","author":"A Chatzara","year":"2019","unstructured":"Chatzara A, Chronopoulou I, Theodossiadis G, Theodossiadis P, Chatziralli I. XEN implant for glaucoma treatment: a review of the literature. Semin Ophthalmol. 2019;34:93\u20137.","journal-title":"Semin Ophthalmol"},{"key":"2022_CR9","doi-asserted-by":"publisher","first-page":"e0231614","DOI":"10.1371\/journal.pone.0231614","volume":"15","author":"FM Wagner","year":"2020","unstructured":"Wagner FM, Schuster AK, Emmerich J, Chronopoulos P, Hoffmann EM. Efficacy and safety of XEN\u00ae-Implantation vs. trabeculectomy: data of a \u201creal-world\u201d setting. PLoS ONE. 2020;15:e0231614.","journal-title":"PLoS ONE"},{"key":"2022_CR10","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00417-019-04341-y","volume":"257","author":"MT Marcos Parra","year":"2019","unstructured":"Marcos Parra MT, Salinas Lopez JA, Lopez Grau NS, Ceausescu AM, Perez Santonja JJ. XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2019;257:1741\u201350.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2022_CR11","first-page":"1941","volume":"11","author":"AL Bas\u00edlio","year":"2018","unstructured":"Bas\u00edlio AL, Moura-Coelho N, Passos I, Cardoso MS, Domingues I, Reina M, et al. XEN(\u00ae) implant and trabeculectomy medium-term quality of life assessment and comparison of results. Int J Ophthalmol. 2018;11:1941\u20134.","journal-title":"Int J Ophthalmol"},{"key":"2022_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00417-018-3899-7","volume":"256","author":"RA Widder","year":"2018","unstructured":"Widder RA, Dietlein TS, Dinslage S, Kuhnrich P, Rennings C, Rossler G. The XEN45 Gel Stent as a minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol. 2018;256:765\u201371.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2022_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/IJG.0000000000001122","volume":"28","author":"A Heidinger","year":"2019","unstructured":"Heidinger A, Schwab C, Lindner E, Riedl R, Mossbock G. A retrospective study of 199 Xen45 stent implantations from 2014 to 2016. J Glaucoma. 2019;28:75\u20139.","journal-title":"J Glaucoma."},{"key":"2022_CR14","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.ophtha.2017.05.004","volume":"124","author":"MB Schlenker","year":"2017","unstructured":"Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I, et al. Efficacy, safety, and risk factors for failure of standalone ab interno gelatin microstent implantation versus standalone trabeculectomy. Ophthalmology. 2017;124:1579\u201388.","journal-title":"Ophthalmology."},{"key":"2022_CR15","first-page":"Cd012742","volume":"12","author":"AJ King","year":"2018","unstructured":"King AJ, Shah A, Nikita E, Hu K, Mulvaney CA, Stead R, et al. Subconjunctival draining minimally-invasive glaucoma devices for medically uncontrolled glaucoma. Cochrane Database Syst Rev. 2018;12:Cd012742.","journal-title":"Cochrane Database Syst Rev"},{"key":"2022_CR16","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1001\/jamaophthalmol.2021.2351","volume":"139","author":"AK Bicket","year":"2021","unstructured":"Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, et al. Minimally invasive glaucoma surgical techniques for open-angle glaucoma: an overview of cochrane systematic reviews and network meta-analysis. JAMA Ophthalmol. 2021;139:983\u20139.","journal-title":"JAMA Ophthalmol."},{"key":"2022_CR17","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1007\/s00417-021-05189-x","volume":"259","author":"SY Lim","year":"2021","unstructured":"Lim SY, Betzler BK, Yip LWL, Dorairaj S, Ang BCH. Standalone XEN45 Gel Stent Implantation Versus Combined XEN45-phacoemulsification in the treatment of open angle glaucoma-a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol. 2021;259:3209\u201319.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2022_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006\u201312.","journal-title":"J Clin Epidemiol"},{"key":"2022_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi S, R\u00fccker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153\u201360.","journal-title":"Evid Based Ment Health"},{"key":"2022_CR20","unstructured":"Team RC. R Core Team. R: a language and environment for statistical computing. Found Stat Comput. 2013."},{"key":"2022_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40123-019-0192-8","volume":"8","author":"AG Kalina","year":"2019","unstructured":"Kalina AG, Kalina PH, Brown MM. XEN\u00ae gel stent in medically refractory open-angle glaucoma: results and observations after one year of use in the United States. Ophthalmol Ther. 2019;8:435\u201346.","journal-title":"Ophthalmol Ther"},{"key":"2022_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41433-018-0243-8","volume":"33","author":"A Karimi","year":"2019","unstructured":"Karimi A, Lindfield D, Turnbull A, Dimitriou C, Bhatia B, Radwan M, et al. A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery. Eye. 2019;33:469\u201377.","journal-title":"Eye"},{"key":"2022_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/IJG.0000000000000858","volume":"27","author":"K Mansouri","year":"2018","unstructured":"Mansouri K, Guidotti J, Rao HL, Ouabas A, D'Alessandro E, Roy S, et al. Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN gel implant surgery: 1-year results. J Glaucoma. 2018;27:140\u20137.","journal-title":"J Glaucoma"},{"key":"2022_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10792-019-01271-w","volume":"40","author":"A Olgun","year":"2020","unstructured":"Olgun A, Aktas Z, Ucgul AY. XEN gel implant versus gonioscopy-assisted transluminal trabeculotomy for the treatment of open-angle glaucoma. Int Ophthalmol. 2020;40:1085\u201393.","journal-title":"Int Ophthalmol"},{"key":"2022_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/j.jcrs.0000000000000065","volume":"46","author":"AM Fea","year":"2020","unstructured":"Fea AM, Bron AM, Economou MA, Laffi G, Martini E, Figus M, et al. European study of the efficacy of a cross-linked gel stent for the treatment of glaucoma. J Cataract Refract Surg. 2020;46:441\u201350.","journal-title":"J Cataract Refract Surg"},{"key":"2022_CR26","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s10792-020-01284-w","volume":"40","author":"JY Hu","year":"2020","unstructured":"Hu JY, Ang BCH, Yip LW. Efficacy of the XEN gel stent on intraocular pressure lowering in East Asian eyes. Int Ophthalmol. 2020;40:1191\u20139.","journal-title":"Int Ophthalmol"},{"key":"2022_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5935\/0004-2749.20170093","volume":"80","author":"SA Ozal","year":"2017","unstructured":"Ozal SA, Kaplaner O, Basar BB, Guclu H, Ozal E. An innovation in glaucoma surgery: XEN45 gel stent implantation. Arq Bras Oftalmol. 2017;80:382\u20135.","journal-title":"Arq Bras Oftalmol"},{"key":"2022_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","volume":"257","author":"H Reitsamer","year":"2019","unstructured":"Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I, et al. Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol. 2019;257:983\u201396.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2022_CR29","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/s41433-018-0310-1","volume":"33","author":"M Smith","year":"2019","unstructured":"Smith M, Charles R, Abdel-Hay A, Shah B, Byles D, Lim LA, et al. 1-year outcomes of the Xen45 glaucoma implant. Eye. 2019;33:761\u20136.","journal-title":"Eye"},{"key":"2022_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61319-1","volume":"10","author":"J Buffault","year":"2020","unstructured":"Buffault J, Graber M, Bensmail D, Bluwol \u00c9, Jeanteur MN, Abitbol O, et al. Efficacy and safety at 6 months of the XEN implant for the management of open angle glaucoma. Sci Rep. 2020;10:4527.","journal-title":"Sci Rep"},{"key":"2022_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1097\/IJG.0000000000001501","volume":"29","author":"CA Cutolo","year":"2020","unstructured":"Cutolo CA, Iester M, Bagnis A, Bonzano C, Negri L, Olivari S, et al. Early Postoperative Intraocular Pressure is Associated With Better Pressure Control After XEN Implantation. J Glaucoma. 2020;29:456\u201360.","journal-title":"J Glaucoma"},{"key":"2022_CR32","doi-asserted-by":"publisher","unstructured":"Dar N, Sharon T, Hecht I, Kalev-Landoy M, Burgansky-Eliash Z. Efficacy and safety of the ab interno gelatin stent in severe pseudoexfoliation glaucoma compared to non-pseudoexfoliation glaucoma at 6 months. Eur J Ophthalmol. 2019. https:\/\/doi.org\/10.1177\/1120672119848277.","DOI":"10.1177\/1120672119848277"},{"key":"2022_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/ceo.13463","volume":"47","author":"M Lenzhofer","year":"2019","unstructured":"Lenzhofer M, Kersten-Gomez I, Sheybani A, Gulamhusein H, Strohmaier C, Hohensinn M, et al. Four-year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi-centre study. Clin Exp Ophthalmol. 2019;47:581\u20137.","journal-title":"Clin Exp Ophthalmol"},{"key":"2022_CR34","first-page":"9364910","volume":"2017","author":"AM Fea","year":"2017","unstructured":"Fea AM, Spinetta R, Cannizzo PML, Consolandi G, Lavia C, Aragno V, et al. Evaluation of bleb morphology and reduction in IOP and glaucoma medication following implantation of a novel gel stent. J Ophthalmol. 2017;2017:9364910.","journal-title":"J Ophthalmol"},{"key":"2022_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10792-019-01232-3","volume":"40","author":"A Fernandez-Garcia","year":"2020","unstructured":"Fernandez-Garcia A, Zhou Y, Garcia-Alonso M, Andrango HD, Poyales F, Garzon N. Medium-term clinical outcomes following Xen45 device implantation. Int Ophthalmol. 2020;40:709\u201315.","journal-title":"Int Ophthalmol"},{"key":"2022_CR36","doi-asserted-by":"crossref","first-page":"5457246","DOI":"10.1155\/2017\/5457246","volume":"2017","author":"A Galal","year":"2017","unstructured":"Galal A, Bilgic A, Eltanamly R, Osman A. XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol. 2017;2017:5457246.","journal-title":"J Ophthalmol"},{"key":"2022_CR37","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/IJG.0000000000000803","volume":"26","author":"FH Hengerer","year":"2017","unstructured":"Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I. Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma. 2017;26:1130\u20136.","journal-title":"J Glaucoma"},{"key":"2022_CR38","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/IJG.0000000000001295","volume":"28","author":"K Gillmann","year":"2019","unstructured":"Gillmann K, Bravetti GE, Mermoud A, Rao HL, Mansouri K. XEN gel stent in pseudoexfoliative glaucoma: 2-year results of a prospective evaluation. J Glaucoma. 2019;28:676\u201384.","journal-title":"J Glaucoma"},{"key":"2022_CR39","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s10792-017-0571-x","volume":"38","author":"A De Gregorio","year":"2018","unstructured":"De Gregorio A, Pedrotti E, Russo L, Morselli S. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol. 2018;38:1129\u201334.","journal-title":"Int Ophthalmol"},{"key":"2022_CR40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/1120672118795063","volume":"29","author":"A Ib\u00e1\u00f1ez-Mu\u00f1oz","year":"2019","unstructured":"Ib\u00e1\u00f1ez-Mu\u00f1oz A, Soto-Biforcos VS, Chac\u00f3n-Gonz\u00e1lez M, R\u00faa-Galisteo O, Arrieta-Los Santos A, Lizuain-Abad\u00eda ME, et al. One-year follow-up of the XEN(R) implant with mitomycin-C in pseudoexfoliative glaucoma patients. Eur J Ophthalmol. 2019;29:309\u201314.","journal-title":"Eur J Ophthalmol"},{"key":"2022_CR41","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ajo.2017.07.023","volume":"183","author":"DS Grover","year":"2017","unstructured":"Grover DS, Flynn WJ, Bashford KP, Lewis RA, Duh YJ, Nangia RS, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25\u201336.","journal-title":"Am J Ophthalmol"},{"key":"2022_CR42","doi-asserted-by":"publisher","unstructured":"Ib\u00e1\u00f1ez-Mu\u00f1oz A, Soto-Biforcos VS, Rodr\u00edguez-Vicente L, Ortega-Renedo I, Chac\u00f3n-Gonz\u00e1lez M, R\u00faa-Galisteo O, et al. XEN implant in primary and secondary open-angle glaucoma: a 12-month retrospective study. Eur J Ophthalmol. 2019. https:\/\/doi.org\/10.1177\/1120672119845226.","DOI":"10.1177\/1120672119845226"},{"key":"2022_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4103\/meajo.MEAJO_126_19","volume":"26","author":"D Laroche","year":"2019","unstructured":"Laroche D, Nkrumah G, Ng C. Real-world retrospective consecutive study of ab interno XEN 45 gel stent implant with mitomycin C in Black and Afro-Latino patients with glaucoma: 40% required secondary glaucoma surgery at 1 year. Middle East Afr J Ophthalmol. 2019;26:229\u201334.","journal-title":"Middle East Afr J Ophthalmol"},{"key":"2022_CR44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.oftal.2017.02.010","volume":"92","author":"\u00c1 Olate-P\u00e9rez","year":"2017","unstructured":"Olate-P\u00e9rez \u00c1, P\u00e9rez-Torregrosa VT, Gargallo-Benedicto A, Neira-Ib\u00e1\u00f1ez P, Cerd\u00e0-Ib\u00e1\u00f1ez M, Osorio-Alayo V, et al. Prospective study of filtering blebs after XEN45 surgery. Arch Soc Esp Oftalmol. 2017;92:366\u201371.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2022_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.oftal.2016.02.006","volume":"91","author":"VT P\u00e9rez-Torregrosa","year":"2016","unstructured":"P\u00e9rez-Torregrosa VT, Olate-P\u00e9rez \u00c1, Cerd\u00e0-Ib\u00e1\u00f1ez M, Gargallo-Benedicto A, Osorio-Alayo V, Barreiro-Rego A, et al. Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol. 2016;91:415\u201321.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"2022_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10633-020-09753-4","volume":"141","author":"M Post","year":"2020","unstructured":"Post M, Lubinski W, Sliwiak D, Podboraczynska-Jodko K, Mularczyk M. XEN gel stent in the management of primary open-angle glaucoma. Doc Ophthalmol. 2020;141:65\u201376.","journal-title":"Doc Ophthalmol"},{"key":"2022_CR47","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1097\/IJG.0000000000001389","volume":"28","author":"A Qureshi","year":"2019","unstructured":"Qureshi A, Jones NP, Au L. Urgent management of secondary glaucoma in uveitis using the Xen-45 gel stent. J Glaucoma. 2019;28:1061\u20136.","journal-title":"J Glaucoma"},{"key":"2022_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/ceo.13087","volume":"46","author":"CC Sng","year":"2018","unstructured":"Sng CC, Wang J, Hau S, Htoon HM, Barton K. XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol. 2018;46:339\u201345.","journal-title":"Clin Exp Ophthalmol"},{"key":"2022_CR49","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/eye.2017.162","volume":"32","author":"SZ Tan","year":"2018","unstructured":"Tan SZ, Walkden A, Au L. One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperative management. Eye. 2018;32:324\u201332.","journal-title":"Eye"},{"key":"2022_CR50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2147\/OPTH.S146919","volume":"12","author":"A De Gregorio","year":"2018","unstructured":"De Gregorio A, Pedrotti E, Stevan G, Bertoncello A, Morselli S. XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice. Clin Ophthalmol. 2018;12:773\u201382.","journal-title":"Clin Ophthalmol"},{"key":"2022_CR51","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1167\/iovs.15-16625","volume":"56","author":"A Sheybani","year":"2015","unstructured":"Sheybani A, Reitsamer H, Ahmed II. Fluid dynamics of a novel micro-fistula implant for the surgical treatment of glaucoma. Investig Ophthalmol Vis Sci. 2015;56:4789\u201395.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2022_CR52","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/IJG.0000000000001146","volume":"28","author":"L Arnould","year":"2019","unstructured":"Arnould L, Theillac V, Moran S, Gatinel D, Grise-Dulac A. Recurrent exposure of XEN gel stent implant and conjunctival erosion. J Glaucoma. 2019;28:e37\u201340.","journal-title":"J Glaucoma"},{"key":"2022_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0540-1","volume":"17","author":"N Dervenis","year":"2017","unstructured":"Dervenis N, Mikropoulou AM, Dervenis P, Lewis A. Dislocation of a previously successful XEN glaucoma implant into the anterior chamber: a case report. BMC Ophthalmol. 2017;17:148.","journal-title":"BMC Ophthalmol"},{"key":"2022_CR54","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/eye.2017.144","volume":"32","author":"E Nikita","year":"2018","unstructured":"Nikita E, Murdoch I. Same-site surgical revision of failed trabeculectomy blebs with mitomycin C augmentation: long-term follow-up. Eye. 2018;32:352\u20138.","journal-title":"Eye"},{"key":"2022_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/IJG.0b013e3181911271","volume":"18","author":"N Anand","year":"2009","unstructured":"Anand N, Khan A. Long-term outcomes of needle revision of trabeculectomy blebs with mitomycin C and 5-fluorouracil: a comparative safety and efficacy report. J Glaucoma. 2009;18:513\u201320.","journal-title":"J Glaucoma"},{"key":"2022_CR56","doi-asserted-by":"publisher","first-page":"e1105","DOI":"10.1111\/aos.14167","volume":"97","author":"M Lenzhofer","year":"2019","unstructured":"Lenzhofer M, Strohmaier C, Sperl P, Hohensinn M, Hitzl W, Steiner V, et al. Effect of the outer stent position on efficacy after minimally invasive transscleral glaucoma gel stent implantation. Acta Ophthalmologica. 2019;97:e1105\u201311.","journal-title":"Acta Ophthalmologica"},{"key":"2022_CR57","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10384-017-0504-2","volume":"61","author":"A Narita","year":"2017","unstructured":"Narita A, Morizane Y, Miyake T, Seguchi J, Baba T, Shiraga F. Characteristics of successful filtering blebs at 1 year after trabeculectomy using swept-source three-dimensional anterior segment optical coherence tomography. Jpn J Ophthalmol. 2017;61:253\u20139.","journal-title":"Jpn J Ophthalmol"},{"key":"2022_CR58","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1111\/aos.14111","volume":"97","author":"M Lenzhofer","year":"2019","unstructured":"Lenzhofer M, Strohmaier C, Hohensinn M, Hitzl W, Sperl P, Gerner M, et al. Longitudinal bleb morphology in anterior segment OCT after minimally invasive transscleral ab interno Glaucoma Gel Microstent implantation. Acta Ophthalmol. 2019;97:e231\u20137.","journal-title":"Acta Ophthalmol"},{"key":"2022_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-021-01949-9","volume":"21","author":"S Arimura","year":"2021","unstructured":"Arimura S, Iwasaki K, Orii Y, Takamura Y, Inatani M. Comparison of 5-year outcomes between trabeculectomy combined with phacoemulsification and trabeculectomy followed by phacoemulsification: a retrospective cohort study. BMC Ophthalmol. 2021;21:188.","journal-title":"BMC Ophthalmol"},{"key":"2022_CR60","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/bjo.78.6.466","volume":"78","author":"D Broadway","year":"1994","unstructured":"Broadway D, Grierson I, Hitchings R. Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important? Br J Ophthalmol. 1994;78:466\u201375.","journal-title":"Br J Ophthalmol"},{"key":"2022_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00061198-200106000-00017","volume":"10","author":"DC Broadway","year":"2001","unstructured":"Broadway DC, Chang LP. Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma. 2001;10:237\u201349.","journal-title":"J Glaucoma"},{"key":"2022_CR62","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/01.icu.0000156137.28193.48","volume":"16","author":"SD Wadhwa","year":"2005","unstructured":"Wadhwa SD, Higginbotham EJ. Ethnic differences in glaucoma: prevalence, management, and outcome. Curr Opin Ophthalmol. 2005;16:101\u20136.","journal-title":"Curr Opin Ophthalmol"},{"key":"2022_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/IJG.0000000000001107","volume":"28","author":"RE Marques","year":"2019","unstructured":"Marques RE, Ferreira NP, Sousa DC, Pinto J, Barata A, Sens P, et al. Glaucoma gel implant learning curve in a teaching Tertiary hospital. J Glaucoma. 2019;28:56\u201360.","journal-title":"J Glaucoma"},{"key":"2022_CR64","unstructured":"Shaarawy T, Grehn F, editors. Guidelines on design and reporting of glaucoma surgical trials. Amsterdam, The Netherlands: Kugler publications; 2009."}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02022-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:20:54Z","timestamp":1700389254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-022-02022-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2022"],"URL":"https:\/\/doi.org\/10.1038\/s41433-022-02022-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BKB and SYL declare no competing interests. BAL has previously received speaker\u2019s honorarium from Allergan plc. VCHY has previously received funds for travel from Allergan plc. BCHA has previously received funds for travel and research, as well as speaker\u2019s honorarium from Allergan plc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}